Surgical Robotics Technology
At the European Association of Neurosurgical Societies (EANS 2025) Congress in Vienna, Austria, Prof. Dr. Ehab Shiban and Dr. Petros Evangelou from the Medizinische Universität Lausitz – Carl-Thiem-Klinikum Cottbus presented the first German clinical experience with NaoTrac, the autonomous neurosurgical navigation robot developed by Brain Navi Biotechnology.
During the first three days of clinical use and training, five patients underwent seven neurosurgical procedures, including biopsies, catheter placements, and craniotomy planning.
According to Prof. Shiban, the system performed patient registration within seconds, reducing anesthesia and preparation time — without the complex setup procedures required by conventional navigation systems.
NaoTrac automatically recognized and calibrated each surgical tool through its unique smart identification system, maintaining workflow consistency and robotic precision.
After the surgeon defined the entry and target points, the robot autonomously followed the planned trajectory with controlled motion as slow as 0.5 mm per second.
This steady and ultra-precise movement enabled access to deep-seated intracranial targets—including lesions in eloquent and hard-to-reach areas such as the thalamus and brainstem—achieving sub-millimeter accuracy with no intraoperative bleeding recorded.
This milestone demonstrates how autonomous robotic assistance can enhance surgical precision, reproducibility, and safety—supporting neurosurgeons while keeping full control in their hands.
In Germany, the NaoTrac program is directed by Nelson Farfan Espada, who brings his experience from a series of world-leading international ventures. Working closely with the Brain Navi engineering team from Taiwan and German service specialists, he drives the initiative behind the scenes to ensure seamless strategic, clinical, and technical alignment.
For hospitals, neurosurgeons, or clinical partners interested in learning more about NaoTrac or its implementation possibilities, please reach out directly for further insights and collaboration details:
